XJSE
ACT
Market cap33mUSD
Oct 09, Last price
66.00ZAR
1D
-2.86%
1Q
-12.82%
Jan 2017
-88.83%
IPO
-83.00%
Name
Afrocentric Investment Corporation Ltd
Chart & performance
P/E
—
P/S
0.07
EPS
—
Div yield, %
8.82%
Shrs. gr., 5y
7.63%
Rev. gr., 5y
-1.99%
Revenues
7.30b
-14.11%
Net income
-1.27b
L+4,324.19%
CFO
685m
+24.97%
Dividend
May 07, 20256 ZAR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AfroCentric Investment Corporation Limited, an investment holding firm established in 2008 and headquartered in Roodepoort, South Africa, focuses on providing comprehensive health administration and risk management solutions to the healthcare industry. The company operates through several key segments: Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology. Its diverse service portfolio includes supplying documentation-based care equipment and administrative support to 12 musculoskeletal treatment centers. Additionally, AfroCentric manages the retail and wholesale distribution of pharmaceutical products through brands such as Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health. The corporation also offers vital management solutions for HIV and other health conditions. Its geographical reach extends across South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe.
Key people
Non-Executive Chairman of the Board · since 2016
Hannes Boonzaaier
Group Chief Financial Officer, Executive Director · since 2015
Aklaaq Mahmood
Executive Director
Gerald Van Wyk
Group Chief Executive Officer, Executive Director · since 2023
Billy Mokale
Group Company Secretary · since 2017
J. Bruno Fernandes
Lead Independent Non-Executive Director · since 2018
M. Joe Madungandaba
Deputy Chairman of the Board · since 2024
Gary Allen
Non-Executive Director · since 2019
Thinus Alsworth-elvey
Non-Executive Director · since 2019
Non-Executive Director · since 2023
Non-Executive Director · since 2023
Karabo Morule
Non-Executive Director · since 2024
Nkateko Munisi
Non-Executive Director · since 2015
Joe Appelgryn
Non-Executive Independent Director · since 2013
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2020
S. Mmakau
Independent Non-Executive Director · since 2016
Independent Non-Executive Director · since 2025
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||